Indoco Remedies Schedules Q3FY26 Earnings Conference Call for Feb 3, 2026
Indoco Remedies Limited will hold an earnings conference call on February 3, 2026, at 3:30 PM IST to discuss financial results for the quarter and nine months ended December 31, 2025. Key management personnel will attend the call.
This is a standard procedural announcement regarding a conference call and does not contain new financial information or strategic decisions that would significantly impact the company's stock or operations.
The announcement is a routine intimation about a scheduled conference call to discuss financial results. It does not contain any performance-related information or forward-looking statements that would suggest a positive or negative sentiment.
Indoco Remedies Limited has announced its upcoming Earnings Conference Call to discuss the Unaudited Financial Results for the Quarter and Nine Months ended December 31, 2025.
The conference call is scheduled to be held on Tuesday, February 3, 2026, at 03:30 p.m. IST. The management team, including Ms. Aditi Panandikar (Managing Director), Mr. Sundeep V Bambolkar (Joint Managing Director), and Mr. Pramod Ghorpade (Chief Financial Officer), will be present to discuss the results.
The call is being organized by Nirmal Bang Institutional Equities. Participants can join using the Diamond Pass™ link: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=3310361&linkSecurityString=1a48f6275f. Universal dial-in numbers are +91 22 6280 1304 and +91 22 7115 8205. International toll-free numbers for various countries are also provided.
What to do with a filing like this
Indoco Remedies Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indoco Remedies Limited. Read the original for the full detail.